SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-236748
Filing Date
2024-10-11
Accepted
2024-10-11 16:52:23
Documents
10
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A d897073dpre14a.htm PRE 14A 457393
2 GRAPHIC g897073g01t02.jpg GRAPHIC 46629
3 GRAPHIC g897073g02p05.jpg GRAPHIC 71840
4 GRAPHIC g897073g19n99.jpg GRAPHIC 3910
5 GRAPHIC g897073g82w67.jpg GRAPHIC 886
6 GRAPHIC g897073new1a.jpg GRAPHIC 60287
7 GRAPHIC g897073sp1a.jpg GRAPHIC 8791
8 GRAPHIC g897073sp1b.jpg GRAPHIC 8593
9 GRAPHIC g897073sp1c.jpg GRAPHIC 8777
10 GRAPHIC g897073sp1d.jpg GRAPHIC 8952
  Complete submission text file 0001193125-24-236748.txt   739395
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39334 | Film No.: 241368057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)